<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04851314</url>
  </required_header>
  <id_info>
    <org_study_id>UCIANES11 [HS# 2014-1248]</org_study_id>
    <nct_id>NCT04851314</nct_id>
  </id_info>
  <brief_title>Comparison of Different Ventilator and Vaporizer Technologies to Study Economic and Environmental Implications</brief_title>
  <official_title>Low-flow Anesthesia: Cost-effectiveness of the FLOW-i Anesthesia Machine, a Comparison to Established Anesthesia Delivery Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test whether or not the use of a low volume ventilator in an&#xD;
      anesthesia machine reduces anesthetic costs significantly as compared to other high volume&#xD;
      machines. The study will compare the a low-flow anesthesia machine to a traditional&#xD;
      anesthesia machine during routine elective general surgery in patients with ASA ratings of&#xD;
      1-2 under general anesthesia receiving standard care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study member will screen for potential subjects using the UCIMC surgical schedule. If a&#xD;
      subject is deemed ineligible based on the inclusion and exclusion criteria after reviewing&#xD;
      the medical history, his/her record will be discarded. No records will be retained from&#xD;
      ineligible subjects. After discussing with the patient's surgeon, study team member will&#xD;
      initiate the informed consent process by approaching each eligible subject to explain the&#xD;
      study and what it entails. The Lead Researcher will address all questions and concerns from&#xD;
      the subject before asking the subject to sign the research consent form.&#xD;
&#xD;
      The GE anesthesia machines currently owned by the operating room will be used to serve as the&#xD;
      comparator to the Flow-i machine. The high volume anesthesia machines do not use a low volume&#xD;
      system. Subjects will be randomized by recruitment day. On a given recruitment day, all&#xD;
      consented subjects will receive anesthesia from one of two groups:&#xD;
&#xD;
      (1) MAQUET FLOW-i device (2) GE anesthetic device&#xD;
&#xD;
      Time points for both groups include:&#xD;
&#xD;
      T0: Time of intubation, when volatile anesthetic are typically first delivered to the&#xD;
      patient. We will use 15L/min fresh gas flow, while dictating tidal volumes of 6-8 mL/kg ideal&#xD;
      body weight and a PEEP of 6 centimeters of water (cm H2O) in accordance with current best&#xD;
      practices.&#xD;
&#xD;
      T1: Time of incision, which typically represents the time of reaching steady state conditions&#xD;
      of volatile anesthetic delivery. We will reduce fresh gas flow to 2 L/min in accordance with&#xD;
      local practice and weigh the vaporizer at this point, allowing us to measure comparative&#xD;
      anesthetic consumption during this wash-in time period (T0-T1).&#xD;
&#xD;
      T2: Time of anesthetic weaning, typically the time when preparing for patient emergence&#xD;
      begins by discontinuing the delivery of volatile anesthetics to the patient. The vaporizer&#xD;
      will be re- weighed at this point, allowing us to measure comparative anesthetic consumption&#xD;
      at steady state maintenance of anesthetic depth (T1-T2) Logically, we will also be able to&#xD;
      use T0-T2 in order to understand total comparative anesthetic consumption.&#xD;
&#xD;
      Aside from the randomization to either Group 1 or Group 2, there will be no changes in the&#xD;
      surgical or anesthetic procedure, including the medication or treatments given to the&#xD;
      subjects as determined by the treating physician. All subjects will receive general&#xD;
      anesthesia in accordance to local practice.&#xD;
&#xD;
      For this study, the vaporizer(s) will be weighed on a tared scale before research procedures&#xD;
      commence, after induction, and when the gas is shut off during weaning of anesthesia in&#xD;
      preparation for extubation to calculate the amount consumed during this time (grams/minute).&#xD;
      In addition, the following variables will be recorded:&#xD;
&#xD;
      Subject weight (kg) Tidal Volume (TV) Respiratory Rate (RR) 9 of 24&#xD;
&#xD;
      Positive end-expiratory pressure (PEEP) Fresh Gas Flow Volume % gas End Tidal (%) Time of&#xD;
      extubation Time when Aldrete score &gt; 8&#xD;
&#xD;
      This is not a physician-blinded study being that the physical characteristics of the standard&#xD;
      delivery units are distinguishable from the MAQUET FLOW-i machine.&#xD;
&#xD;
      All MAC concentrations are standard of care: After the surgical procedure, patient will be&#xD;
      assessed for time to reach Aldrete score greater than 8, level of pain and time to&#xD;
      extubation. Their medical records will be reviewed to determine need for times and adverse&#xD;
      events. Patients will not be contacted for study-related follow-up after they are discharged&#xD;
      from recovery.&#xD;
&#xD;
      No photographs or audio/video recording will be collected for this study.&#xD;
&#xD;
      Subject's Privacy:&#xD;
&#xD;
      The study team member will screen for potential subjects using the UCIMC surgical schedule.&#xD;
      If a subject is deemed ineligible based on the inclusion and exclusion criteria after&#xD;
      reviewing the medical history, his/her record will be discarded. No records will be retained&#xD;
      from ineligible subjects.&#xD;
&#xD;
      Study team member will approach each eligible patient to explain the study and what it&#xD;
      entails. The study team member will address all questions and concerns from the subjects&#xD;
      before asking the patient to sign the research consent form.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 14, 2018</start_date>
  <completion_date type="Actual">November 8, 2019</completion_date>
  <primary_completion_date type="Actual">November 8, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Study Variable: Amount of Gas Vaporized Anesthetic Per Minute Anesthesia</measure>
    <time_frame>Intraoperative (minimum of 2 hours of anesthesia)</time_frame>
    <description>The purpose of this study is to test whether or not the use of a low volume ventilator in an anesthesia machine reduces anesthetic costs significantly as compared to other high volume machines. The study will compare the FLOW-i anesthesia machine to a GE anesthesia machine during routine elective general surgery in patients with ASA ratings of 1-2 under general anesthesia receiving standard care.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Reach Aldrete &gt; 8</measure>
    <time_frame>Up to 24 hours</time_frame>
    <description>Time it took for patient to be safely discharged from the post-anesthesia care unit (PACU).&#xD;
The Aldrete Score evaluates recovery after anesthesia and patient readiness to be discharged from PACU. The patient is assessed for consciousness, mobility, breathing, circulation, and color. The evaluation occurs immediately after surgery and then every (1) hour before the patient is deemed ready for discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Extubation From Weaning</measure>
    <time_frame>Intraoperative (minimum of 2 hours of anesthesia)</time_frame>
    <description>Time it took to remove patient from mechanical ventilation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Anesthetic Gas Consumption and Cost-Effectiveness</condition>
  <arm_group>
    <arm_group_label>ICU certified ventilator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants assigned to receive ventilation with the ICU certified ventilator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-ICU certified ventilator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants assigned to receive ventilation with the Non-ICU certified ventilator</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ICU certified ventilator</intervention_name>
    <description>Examine anesthetic consumption rates</description>
    <arm_group_label>ICU certified ventilator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-ICU certified ventilator</intervention_name>
    <description>Examine anesthetic consumption rates</description>
    <arm_group_label>Non-ICU certified ventilator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-65 years&#xD;
&#xD;
          -  Undergo surgery under general anesthesia in UCI Medical Center&#xD;
&#xD;
          -  Agree to sign the consent and HIPAA forms&#xD;
&#xD;
          -  Subjects who are able to receive sevoflurane&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects under the age of 18&#xD;
&#xD;
          -  Chronic Obstructive Pulmonary Disease (COPD)&#xD;
&#xD;
          -  Body Mass Index (BMI) &gt; 30&#xD;
&#xD;
          -  ASA &gt; 2&#xD;
&#xD;
          -  Pregnant females&#xD;
&#xD;
          -  Procedures less than 2 hours&#xD;
&#xD;
          -  Those with known sensitivity to sevoflurane or other halogenated agents; those with&#xD;
             known or suspected susceptibility to malignant hyperthermia&#xD;
&#xD;
          -  Severe Cardiovascular Disease: Left Ventricular Ejection Fraction (LVEF) &lt; 30%&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert R Field, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Irvine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, Irvine Medical Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Avramov MN, Griffin JD, White PF. The effect of fresh gas flow and anesthetic technique on the ability to control acute hemodynamic responses during surgery. Anesth Analg. 1998 Sep;87(3):666-70.</citation>
    <PMID>9728850</PMID>
  </reference>
  <reference>
    <citation>Choi SU, Shin HW, Jung HI, Park JY, Yoon SZ, Lee YS, Kim WY, Chang SH. Control of the haemodynamic response to surgical stimuli in semi-closed circuit or closed circuit anaesthesia using a multifunctional anaesthesia system. J Int Med Res. 2010 Sep-Oct;38(5):1637-44.</citation>
    <PMID>21309477</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>April 30, 2018</study_first_submitted>
  <study_first_submitted_qc>April 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2021</study_first_posted>
  <results_first_submitted>June 21, 2021</results_first_submitted>
  <results_first_submitted_qc>July 16, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">August 10, 2021</results_first_posted>
  <last_update_submitted>July 16, 2021</last_update_submitted>
  <last_update_submitted_qc>July 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Robert Ryan Field</investigator_full_name>
    <investigator_title>HS/Assistant Clinical Professor; Neuroanesthesiology Clinical Director</investigator_title>
  </responsible_party>
  <keyword>general anesthesia</keyword>
  <keyword>anesthesia machines</keyword>
  <keyword>sevoflurane</keyword>
  <keyword>low volume ventilator</keyword>
  <keyword>anesthetic costs</keyword>
  <keyword>cost-effectiveness</keyword>
  <keyword>fresh gas flow</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 5, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/14/NCT04851314/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 5, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/14/NCT04851314/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Some enrolled subjects were excluded due to unforeseen circumstances in the clinical workflow e.g. a change in anesthetic preference or canceled surgery. Data from these cases could not provide meaningful results for analysis.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Maquet Flow-i C20</title>
          <description>Subjects receiving the Maquet Flow-i C20 anesthetic delivery machine will undergo standardized anesthetic protocol to evaluate anesthetic consumption rates</description>
        </group>
        <group group_id="P2">
          <title>GE Aisys CS2</title>
          <description>Subjects receiving the GE Aisys CS2 anesthetic delivery machine will undergo standardized anesthetic protocol to evaluate anesthetic consumption rates</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
                <participants group_id="P2" count="55"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Unable to complete research set-up procedures</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Change in Anesthesia Plan (patient no longer meets inclusion criteria)</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Completed population only</population>
      <group_list>
        <group group_id="B1">
          <title>Maquet Flow-i C20</title>
          <description>Subjects receiving the Maquet Flow-i C20 anesthetic delivery machine will undergo standardized anesthetic protocol to evaluate anesthetic consumption rates.</description>
        </group>
        <group group_id="B2">
          <title>GE Aisys CS2</title>
          <description>Subjects receiving the GE Aisys CS2 anesthetic delivery machine will undergo standardized anesthetic protocol to evaluate anesthetic consumption rates.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="52"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="103"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="52"/>
                    <count group_id="B2" value="51"/>
                    <count group_id="B3" value="103"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42" spread="14"/>
                    <measurement group_id="B2" value="44" spread="13"/>
                    <measurement group_id="B3" value="43" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="52"/>
                    <count group_id="B2" value="51"/>
                    <count group_id="B3" value="103"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Primary Study Variable: Amount of Gas Vaporized Anesthetic Per Minute Anesthesia</title>
        <description>The purpose of this study is to test whether or not the use of a low volume ventilator in an anesthesia machine reduces anesthetic costs significantly as compared to other high volume machines. The study will compare the FLOW-i anesthesia machine to a GE anesthesia machine during routine elective general surgery in patients with ASA ratings of 1-2 under general anesthesia receiving standard care.</description>
        <time_frame>Intraoperative (minimum of 2 hours of anesthesia)</time_frame>
        <population>Completed patient population for each ventilator type</population>
        <group_list>
          <group group_id="O1">
            <title>Maquet Flow-i C20</title>
            <description>Maquet Flow-i C20 (ICU certified ventilator): Examine anesthetic consumption rates</description>
          </group>
          <group group_id="O2">
            <title>GE Aisys CS2</title>
            <description>GE Aisys CS2 (Non-ICU certified ventilator): Examine anesthetic consumption rates</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Study Variable: Amount of Gas Vaporized Anesthetic Per Minute Anesthesia</title>
          <description>The purpose of this study is to test whether or not the use of a low volume ventilator in an anesthesia machine reduces anesthetic costs significantly as compared to other high volume machines. The study will compare the FLOW-i anesthesia machine to a GE anesthesia machine during routine elective general surgery in patients with ASA ratings of 1-2 under general anesthesia receiving standard care.</description>
          <population>Completed patient population for each ventilator type</population>
          <units>grams/minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.48" spread="49.29"/>
                    <measurement group_id="O2" value="119.3" spread="62.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Reach Aldrete &gt; 8</title>
        <description>Time it took for patient to be safely discharged from the post-anesthesia care unit (PACU).&#xD;
The Aldrete Score evaluates recovery after anesthesia and patient readiness to be discharged from PACU. The patient is assessed for consciousness, mobility, breathing, circulation, and color. The evaluation occurs immediately after surgery and then every (1) hour before the patient is deemed ready for discharge.</description>
        <time_frame>Up to 24 hours</time_frame>
        <population>same as primary outcome measure</population>
        <group_list>
          <group group_id="O1">
            <title>Maquet Flow-i C20</title>
            <description>Maquet Flow-i C20 (ICU certified ventilator): Examine anesthetic consumption rates</description>
          </group>
          <group group_id="O2">
            <title>GE Aisys CS2</title>
            <description>GE Aisys CS2 (Non-ICU certified ventilator): Examine anesthetic consumption rates</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Reach Aldrete &gt; 8</title>
          <description>Time it took for patient to be safely discharged from the post-anesthesia care unit (PACU).&#xD;
The Aldrete Score evaluates recovery after anesthesia and patient readiness to be discharged from PACU. The patient is assessed for consciousness, mobility, breathing, circulation, and color. The evaluation occurs immediately after surgery and then every (1) hour before the patient is deemed ready for discharge.</description>
          <population>same as primary outcome measure</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.13" spread="51.83"/>
                    <measurement group_id="O2" value="89.18" spread="52.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Extubation From Weaning</title>
        <description>Time it took to remove patient from mechanical ventilation</description>
        <time_frame>Intraoperative (minimum of 2 hours of anesthesia)</time_frame>
        <population>same as primary outcome</population>
        <group_list>
          <group group_id="O1">
            <title>Maquet Flow-i C20</title>
            <description>Maquet Flow-i C20 (ICU certified ventilator): Examine anesthetic consumption rates</description>
          </group>
          <group group_id="O2">
            <title>GE Aisys CS2</title>
            <description>GE Aisys CS2 (Non-ICU certified ventilator): Examine anesthetic consumption rates</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Extubation From Weaning</title>
          <description>Time it took to remove patient from mechanical ventilation</description>
          <population>same as primary outcome</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.37" spread="6.321"/>
                    <measurement group_id="O2" value="10.78" spread="6.413"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Through study completion, approximately 24 hours</time_frame>
      <desc>As study did not deviate from the standard of care in use of FDA approved devices, any possible adverse event and/or serious adverse event would be the same standard of care.</desc>
      <group_list>
        <group group_id="E1">
          <title>Maquet Flow-i C20</title>
          <description>Subjects receiving the Maquet Flow-i C20 anesthetic delivery machine will undergo standardized anesthetic protocol to evaluate anesthetic consumption rates</description>
        </group>
        <group group_id="E2">
          <title>GE Aisys CS2</title>
          <description>Subjects receiving the GE Aisys CS2 anesthetic delivery machine will undergo standardized anesthetic protocol to evaluate anesthetic consumption rates</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Some overall limitations include include, but are not limited to: a small overall sample size, fluctuations in the concentration of volatile agent setting or fresh gas flow (due to positioning during surgical preparation), and variations in time precision provider charting of the secondary endpoints (weaning, gas off, time in recovery, recovery criteria completion). Protocol procedures were standardized, however lack of blinding is something the authors could not feasibly account for.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Robert Ryan Field</name_or_title>
      <organization>UC Irvine Health</organization>
      <phone>7145065703</phone>
      <email>fieldr@uci.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

